Followers | 504 |
Posts | 10140 |
Boards Moderated | 0 |
Alias Born | 04/28/2014 |
Friday, October 03, 2014 11:32:13 AM
bullish long term investor buy and hold
dollar cost averaging, buy some each month purchase methods, etc...
$REGN recent news/filings
## source: finance.yahoo.com
Thu, 02 Oct 2014 19:33:00 GMT ~ Cholesterol Drugs Haunted By Ghosts Of Past, Present, And Future
read full: http://www.forbes.com/sites/larryhusten/2014/10/02/cholesterol-drugs-haunted-by-ghosts-of-past-present-and-future/?partner=yahootix
*********************************************************
Wed, 01 Oct 2014 23:52:00 GMT ~ Alibaba Among 5 Stocks With Superior Long-Term Growth
read full: http://news.investors.com/100114-719905-alibaba-gopro-top-stocks-with-strong-earnings-sales.htm?ven=yahoocp&src=aurlled&ven=yahoo
*********************************************************
Wed, 01 Oct 2014 21:00:00 GMT ~ Why October could be bad for biotech
[Talking Numbers] - http://l.yimg.com/hv/api/res/1.2/OP9H_i06LQvRMU8bJ8PhOA--/YXBwaWQ9eWZpbmFuY2U7aD0zMTt3PTQy/http://l.yimg.com/os/en-US/video/video.pd2upload.com/video.tncnbc.com@a1ad4509-2d80-3112-a3c4-b525b395d709_FULL.jpg
read full: http://finance.yahoo.com/blogs/talking-numbers/why-october-could-be-bad-for-biotech-130332241.html
*********************************************************
Tue, 30 Sep 2014 19:04:00 GMT ~ Stocks Move To Session Lows; Regeneron Rises On Drug Data
read full: http://news.investors.com/093014-719590-ebay-outperforms-on-news-of-paypal-spinoff.htm?ven=yahoocp&src=aurlled&ven=yahoo
*********************************************************
Tue, 30 Sep 2014 17:31:00 GMT ~ [video] Q4 momentum
read full: http://video.cnbc.com/gallery/?video=3000315851&__source=yahoo%7cheadline%7cquote%7cvideo%7c&par=yahoo
*********************************************************
$REGN charts
basic chart ## source: stockcharts.com
basic chart ## source: stockscores.com
big daily chart ## source: stockcharts.com
big weekly chart ## source: stockcharts.com
$REGN company information
## source: otcmarkets.com
Link: http://www.otcmarkets.com/stock/REGN/company-info
Ticker: $REGN
OTC Market Place: Not Available
CIK code: 0000872589
Company name: Regeneron Pharmaceuticals, Inc.
Incorporated In: NY, USA
$REGN share structure
## source: otcmarkets.com
Market Value: $35,045,935,310 a/o Oct 02, 2014
Shares Outstanding: 99,086,588 a/o Jul 17, 2014
Float: Not Available
Authorized Shares: Not Available
Par Value: 0.001
$REGN extra dd links
Company name: Regeneron Pharmaceuticals, Inc.
## STOCK DETAILS ##
After Hours Quote (nasdaq.com): http://www.nasdaq.com/symbol/REGN/after-hours
Option Chain (nasdaq.com): http://www.nasdaq.com/symbol/REGN/option-chain
Historical Prices (yahoo.com): http://finance.yahoo.com/q/hp?s=REGN+Historical+Prices
Company Profile (yahoo.com): http://finance.yahoo.com/q/pr?s=REGN+Profile
Industry (yahoo.com): http://finance.yahoo.com/q/in?s=REGN+Industry
## COMPANY NEWS ##
Market Stream (nasdaq.com): http://www.nasdaq.com/symbol/REGN/stream
Latest news (otcmarkets.com): http://www.otcmarkets.com/stock/REGN/news - http://finance.yahoo.com/q/h?s=REGN+Headlines
## STOCK ANALYSIS ##
Analyst Research (nasdaq.com): http://www.nasdaq.com/symbol/REGN/analyst-research
Guru Analysis (nasdaq.com): http://www.nasdaq.com/symbol/REGN/guru-analysis
Stock Report (nasdaq.com): http://www.nasdaq.com/symbol/REGN/stock-report
Competitors (nasdaq.com): http://www.nasdaq.com/symbol/REGN/competitors
Stock Consultant (nasdaq.com): http://www.nasdaq.com/symbol/REGN/stock-consultant
Stock Comparison (nasdaq.com): http://www.nasdaq.com/symbol/REGN/stock-comparison
Investopedia (investopedia.com): http://www.investopedia.com/markets/stocks/REGN/?wa=0
Research Reports (otcmarkets.com): http://www.otcmarkets.com/stock/REGN/research
Basic Tech. Analysis (yahoo.com): http://finance.yahoo.com/q/ta?s=REGN+Basic+Tech.+Analysis
Barchart (barchart.com): http://www.barchart.com/quotes/stocks/REGN
DTCC (dtcc.com): http://search2.dtcc.com/?q=Regeneron+Pharmaceuticals%2C+Inc.&x=10&y=8&sp_p=all&sp_f=ISO-8859-1
Spoke company information (spoke.com): http://www.spoke.com/search?utf8=%E2%9C%93&q=Regeneron+Pharmaceuticals%2C+Inc.
Corporation WIKI (corporationwiki.com): http://www.corporationwiki.com/search/results?term=Regeneron+Pharmaceuticals%2C+Inc.&x=0&y=0
## FUNDAMENTALS ##
Call Transcripts (nasdaq.com): http://www.nasdaq.com/symbol/REGN/call-transcripts
Annual Report (companyspotlight.com): http://www.companyspotlight.com/library/companies/keyword/REGN
Income Statement (nasdaq.com): http://www.nasdaq.com/symbol/REGN/financials?query=income-statement
Revenue/EPS (nasdaq.com): http://www.nasdaq.com/symbol/REGN/revenue-eps
SEC Filings (nasdaq.com): http://www.nasdaq.com/symbol/REGN/sec-filings
Edgar filings (sec.gov): http://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0000872589&owner=exclude&count=40
Latest filings (otcmarkets.com): http://www.otcmarkets.com/stock/REGN/filings
Latest financials (otcmarkets.com): http://www.otcmarkets.com/stock/REGN/financials
Short Interest (nasdaq.com): http://www.nasdaq.com/symbol/REGN/short-interest
Dividend History (nasdaq.com): http://www.nasdaq.com/symbol/REGN/dividend-history
RegSho (regsho.com): http://www.regsho.com/tools/symbol_stats.php?sym=REGN&search=search
OTC Short Report (otcshortreport.com): http://otcshortreport.com/index.php?index=REGN
Short Sales (otcmarkets.com): http://www.otcmarkets.com/stock/REGN/short-sales
Key Statistics (yahoo.com): http://finance.yahoo.com/q/ks?s=REGN+Key+Statistics
Insider Roster (yahoo.com): http://finance.yahoo.com/q/ir?s=REGN+Insider+Roster
Income Statement (yahoo.com): http://finance.yahoo.com/q/is?s=REGN
Balance Sheet (yahoo.com): http://finance.yahoo.com/q/bs?s=REGN
Cash Flow (yahoo.com): http://finance.yahoo.com/q/cf?s=REGN+Cash+Flow&annual
## HOLDINGS ##
Major holdings (cnbc.com): http://data.cnbc.com/quotes/REGN/tab/8.1
Insider transactions (yahoo.com): http://finance.yahoo.com/q/it?s=REGN+Insider+Transactions
Insider transactions (secform4.com): http://www.secform4.com/insider-trading/REGN.htm
Insider transactions (insidercrow.com): http://www.insidercow.com/history/company.jsp?company=REGN
Ownership Summary (nasdaq.com): http://www.nasdaq.com/symbol/REGN/ownership-summary
Institutional Holdings (nasdaq.com): http://www.nasdaq.com/symbol/REGN/institutional-holdings
Insiders (SEC Form 4) (nasdaq.com): http://www.nasdaq.com/symbol/REGN/insider-trades
Insider Disclosure (otcmarkets.com): http://www.otcmarkets.com/stock/REGN/insider-transactions
## SOCIAL MEDIA AND OTHER VARIOUS SOURCES ##
PST (pennystocktweets.com): http://www.pennystocktweets.com/stocks/profile/REGN
Market Watch (marketwatch.com): http://www.marketwatch.com/investing/stock/REGN
Bloomberg (bloomberg.com): http://www.bloomberg.com/quote/REGN:US
Morningstar (morningstar.com): http://quotes.morningstar.com/stock/s?t=REGN
Bussinessweek (businessweek.com): http://investing.businessweek.com/research/stocks/snapshot/snapshot_article.asp?ticker=REGN
$REGN DD Notes ~ http://www.ddnotesmaker.com/REGN
Recent REGN News
- Three-year Results for EYLEA HD® (aflibercept) Injection 8 mg Demonstrate Continued Durable Vision Gains and Anatomic Improvements with Extended Dosing Intervals in Patients with Diabetic Macular Edema • GlobeNewswire Inc. • 10/18/2024 09:05:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/07/2024 11:00:27 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/03/2024 08:02:21 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/03/2024 08:02:07 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 10/01/2024 08:13:23 PM
- Dupixent® (dupilumab) Approved in the U.S. as the First-ever Biologic Medicine for Patients with COPD • GlobeNewswire Inc. • 09/27/2024 01:35:08 PM
- Dupixent® (dupilumab) Approved in China as the First-ever Biologic Medicine for Patients with Chronic Obstructive Pulmonary Disease (COPD) • GlobeNewswire Inc. • 09/27/2024 11:00:04 AM
- Regeneron to Report Third Quarter 2024 Financial and Operating Results and Host Conference Call and Webcast on October 31, 2024 • GlobeNewswire Inc. • 09/26/2024 08:05:00 PM
- Dupixent® (dupilumab) Recommended for EU Approval by the CHMP to Treat Eosinophilic Esophagitis (EoE) in Children as Young as 1 Year Old • GlobeNewswire Inc. • 09/20/2024 11:45:00 AM
- Dupixent® (dupilumab) Approved in the U.S. as First and Only Treatment for Adolescents with Chronic Rhinosinusitis with Nasal Polyps (CRSwNP) • GlobeNewswire Inc. • 09/13/2024 04:15:28 PM
- EYLEA HD® (aflibercept) Injection 8 mg Data at EURETINA Reinforce Long-term Durability, Sustained Fluid Control and Safety Profile • GlobeNewswire Inc. • 09/11/2024 11:00:46 AM
- Libtayo® (cemiplimab) Demonstrates Durable Survival Benefit at Five Years in Advanced Non-small Cell Lung Cancer • GlobeNewswire Inc. • 09/09/2024 09:00:00 PM
- Regeneron to Highlight Progress Across Its Differentiated Oncology Portfolio and Pipeline at WCLC and ESMO • GlobeNewswire Inc. • 09/09/2024 11:00:17 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/05/2024 08:01:57 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/05/2024 08:01:28 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/05/2024 08:01:10 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 09/03/2024 08:04:08 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/29/2024 08:27:40 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 08/28/2024 08:35:33 PM
- Ordspono™ (odronextamab) Approved in the European Union for the Treatment of Relapsed/Refractory Follicular Lymphoma and Diffuse Large B-cell Lymphoma • GlobeNewswire Inc. • 08/26/2024 11:00:00 AM
- Latest Dupixent® (dupilumab) and Itepekimab Data at ERS Highlight Scientific Innovation and Leadership in Respiratory Diseases • GlobeNewswire Inc. • 08/26/2024 05:00:00 AM
- Regeneron Provides Update on Biologics License Application for Linvoseltamab • GlobeNewswire Inc. • 08/20/2024 10:45:05 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/19/2024 08:02:05 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/19/2024 08:01:37 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 08/15/2024 09:55:04 PM
SANUWAVE Announces Reverse Stock Split, Note and Warrant Exchange, and PIPE Offering • SNWV • Oct 18, 2024 9:31 AM
Vocodia Addresses Recent Stock Price Movement and Future Strategic Partnerships • VHAI • Oct 18, 2024 9:00 AM
Mass Megawatts Announces the Start of an Online Discount Solar Energy Equipment Business with Revenue Recognized for the First Time Since Year 2010 in this Fiscal Quarter • MMMW • Oct 18, 2024 7:32 AM
Unitronix Corp Advances DeFi Innovation with Tokenized Real-World Assets Integration • UTRX • Oct 17, 2024 7:38 AM
Mass Megawatts Commences Solar Energy Sales Efforts • MMMW • Oct 16, 2024 7:45 AM
SANUWAVE Health Announces 1-For-375 Reverse Stock Split • SNWV • Oct 16, 2024 7:40 AM